Impact of perioperative high-protein nutritional support on the quality of life of patients with primary lung cancer: a Russian prospective multicenter comparative study (NUTRILUNC study)
- Authors: Obukhova O.A.1, Kurmukov I.A.1, Egofarov N.M.2, Kolesnichenko M.G.3,4, Kirillov Y.V.3,4, Povaga S.S.5, Belyaeva N.A.6, Gordeeva E.V.7, Perminov Y.V.8, Skorokhod A.A.8, Nefedov A.O.8, Novitsky D.N.9, Egofarov T.N.10
-
Affiliations:
- N.N. Blokhin National Medical Research Center of Oncology
- Nutricia LLC
- Medical Center “Verax-Med” LLC
- North-Western State Medical University named after I.I. Mechnikov
- Smolensk Regional Clinical Oncology Dispensary
- Clinical hospital “Russian Railways-Medicine”
- Moscow Multidisciplinary Center for Palliative Care
- Saint Petersburg State Research Institute of Phthisiopulmonology
- Clinical Oncology Dispensary
- Medical University REAVIZ
- Issue: Vol 4, No 4 (2023)
- Pages: 211-222
- Section: Original Study Articles
- URL: https://journals.rcsi.science/2658-4433/article/view/272903
- DOI: https://doi.org/10.17816/clinutr630401
- ID: 272903
Cite item
Full Text
Abstract
BACKGROUND: Individuals over the age of 70 comprise over half of operable patients with stage 0–IIIA lung cancer. In the early postoperative period of this cohort, pain, fatigue, insomnia, and/or mood disturbances are the four most common symptoms, which can significantly diminish quality of life and functional status. Perioperative nutritional support in such patients, which enhances exercise tolerance, can have a positive impact on their quality of life and socialization.
AIM: To assess the effect of perioperative nutritional support using high-protein oral nutrition supplements on the general health and quality of life of non-small cell lung cancer patients during the postoperative period.
MATERIALS AND METHODS: Patients with primary non-small cell lung cancer (n=112, 69 males), aged 57.2±8.2, who were awaiting lung surgery and at risk of malnutrition (Nutritional Risk Screening Assessment 2002 score ≥3) were randomly assigned into two groups. Oral nutritional support (Nutridrink Compact Protein, Nutricia LLC) was administered to the study group (n=55) at a rate of 250 ml/d (36 g of protein, 612 kcal) for 14 days prior to and 14 days following the surgery, in addition to the standard diet. Control group patients (n=57) were provided a standard diet. The quality of life was assessed using the Quality of Life Questionnaire Core-30. Results are presented as mean ± standard deviation. Differences were considered significant at p ≤0.05.
RESULTS: Throughout the entire observation period, the study group exhibited superior growth indicators in terms of general health status, physical, and role functioning than the control group (p <0.05). The study group patients exhibited a propensity toward improved emotional functioning, and by the end of the study, weakness and insomnia were less pronounced (p <0.05). Other indicators did not exhibit any significant variations.
CONCLUSION: Нigh-protein perioperative oral nutrition supplements exert a positive impact on the quality of life of non-small cell lung cancer patients.
Full Text
##article.viewOnOriginalSite##About the authors
Olga A. Obukhova
N.N. Blokhin National Medical Research Center of Oncology
Author for correspondence.
Email: obukhova0404@yandex.ru
ORCID iD: 0000-0003-0197-7721
SPIN-code: 6876-7701
MD, Cand. Sci. (Medicine)
Russian Federation, MoscowIldar A. Kurmukov
N.N. Blokhin National Medical Research Center of Oncology
Email: kurmukovia@gmail.com
ORCID iD: 0000-0001-8463-2600
SPIN-code: 3692-5202
MD, Cand. Sci. (Medicine)
Russian Federation, MoscowNail M. Egofarov
Nutricia LLC
Email: nail.egofarov@danone.com
ORCID iD: 0000-0001-5013-0231
Russian Federation, Moscow
Mariya G. Kolesnichenko
Medical Center “Verax-Med” LLC; North-Western State Medical University named after I.I. Mechnikov
Email: maria_2182@mail.ru
MD, Cand. Sci. (Medicine)
Russian Federation, Saint Petersburg; Saint PetersburgYuriy V. Kirillov
Medical Center “Verax-Med” LLC; North-Western State Medical University named after I.I. Mechnikov
Email: Yura-1992@mail.ru
SPIN-code: 1186-9704
Russian Federation, Saint Petersburg; Saint Petersburg
Svetlana S. Povaga
Smolensk Regional Clinical Oncology Dispensary
Email: povaga1980@mail.ru
ORCID iD: 0000-0001-6606-606X
Russian Federation, Smolensk
Natal’ya A. Belyaeva
Clinical hospital “Russian Railways-Medicine”
Email: n.makar1973@mail.ru
ORCID iD: 0000-0001-9616-0030
Russian Federation, Smolensk
Ekaterina V. Gordeeva
Moscow Multidisciplinary Center for Palliative Care
Email: simmetria0@mail.ru
SPIN-code: 9814-3379
Russian Federation, Moscow
Yuriy V. Perminov
Saint Petersburg State Research Institute of Phthisiopulmonology
Email: iuriiperminov88@gmail.com
Russian Federation, Saint Petersburg
Andrey A. Skorokhod
Saint Petersburg State Research Institute of Phthisiopulmonology
Email: dr.skorokhod@mail.ru
ORCID iD: 0000-0002-1819-7206
SPIN-code: 6609-6890
MD, Cand. Sci. (Medicine)
Russian Federation, Saint PetersburgAndrey O. Nefedov
Saint Petersburg State Research Institute of Phthisiopulmonology
Email: herurg78@mail.ru
ORCID iD: 0000-0001-6228-182X
SPIN-code: 2365-9458
MD, Cand. Sci. (Medicine)
Russian Federation, Saint PetersburgDmitriy N. Novitsky
Clinical Oncology Dispensary
Email: dnn1978@gmail.com
Russian Federation, Omsk
Timur N. Egofarov
Medical University REAVIZ
Email: tim7903@gmail.com
ORCID iD: 0009-0007-3620-7811
Russian Federation, Samara
References
- Laktionov KK, Artamonova EV, Borisova TN, et al. Malignant neoplasm of the bronchi and lung: Russian clinical guidelines. Journal of Modern Oncology. 2021;23(3):369–402. doi: 10.26442/18151434.2021.3.201048
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492
- Janssen-Heijnen ML, Smulders S, Lemmens VE, et al. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax. 2004;59(7):602–607. doi: 10.1136/thx.2003.018044
- Cheng X. Effects of lung rehabilitation therapy in improving respiratory motor ability and alleviating dyspnea in patients with lung cancer after lobectomy: a clinical study. Altern Ther Health Med. 2022;28(3):18–23.
- Sommer MS, Staerkind MEB, Christensen J, et al. Effect of postsurgical rehabilitation programmes in patients operated for lung cancer: a systematic review and meta-analysis. J Rehabil Med. 2018;50(3):236–245. doi: 10.2340/16501977-2292
- Chen HL, Liu K, You QS. Self-efficacy, cancer-related fatigue, and quality of life in patients with resected lung cancer. Eur J Cancer Care. 2018;27(6):e12934. doi: 10.1111/ecc.12934
- Obukhova OA, Kurmukov IA, Egofarov NM, et al. Impact of perioperative high-protein nutritional support on postoperative outcomes in the treatment of primary lung cancer: Russian prospective multicenter comparative study (NUTRILUNC-study). Clinical nutrition and metabolism. 2023;4(3):150–164. doi: 10.17816/clinutr625481
- Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376. doi: 10.1093/jnci/85.5.365
- Shin JA, Kosiba JD, Traeger L, et al. Dyspnea and panic among patients with newly diagnosed non-small cell lung cancer. J Pain Symptom Manage. 2014;48:465–470. doi: 10.1016/j.jpainsymman.2013.10.021
- Park S, Kang CH, Hwang Y, et al. Risk factors for postoperative anxiety and depression after surgical treatment for lung cancerdagger. Eur J Cardiothorac Surg. 2016;49:16–21. doi: 10.1093/ejcts/ezv336
- Ivanova AS, Obukhova OA, Kurmukov IA, Volf LY. Review of ESPEN-2021 Practice Guidelines for Cancer Patients: Part 1. Clinical nutrition and metabolism. 2022;3(3):140–152. doi: 10.17816/clinutr111900
- Ivanova AS, Obukhova OA, Kurmukov IA, Volf LY. Review of ESPEN-2021 Practice Guidelines for Patients with Cancer. Part 2: Interventions Relevant to Specific Patient Categories. Clinical nutrition and metabolism. 2022;3(4):193–206. doi: 10.17816/clinutr119059
- Kasprzyk A, Bilmin K, Chmielewska-Ignatowicz T, et al. The role of nutritional support in malnourished patients with lung cancer. In Vivo. 2021;35(1):53–60. doi: 10.21873/invivo.12231
- Krzakowski M, Jassem J, Antczak A, et al. Cancer of the lung, pleura and mediastinum. Oncol Clin Pract. 2019;15:20–50. doi: 10.5603/OCP.2018.0056
- Ramos R, Nadal E, Peiró I, et al. Preoperative nutritional status assessment predicts postoperative outcomes in patients with surgically resected non-small cell lung cancer. Eur J Surg Oncol. 2018;44(9):1419–1424. doi: 10.1016/j.ejso.2018.03.026
- Landgrebe M, Tobberup R, Carus A, Rasmussen HH. GLIM diagnosed malnutrition predicts clinical outcomes and quality of life in patients with non-small cell lung cancer. Clin Nutr. 2023;42(2): 190–198. doi: 10.1016/j.clnu.2022.12.011
- Polański J, Jankowska-Polańska B, Uchmanowicz I, et al. Malnutrition and Quality of Life in Patients with Non-Small-Cell Lung Cancer. Adv Exp Med Biol. 2017;1021:15–26. doi: 10.1007/5584_2017_23
- Ivanova AS, Obukhova OA, Markovich AA, Titova TA. Prevalence of anxiety and depressive disorders in patients with neuroendocrine neoplasia receiving drug treatment. Problems in oncology. 2023;69(3S):396–397. (In Russ). EDN: WRGHIY
- Kupriyanova IE, Choinzonov ETs, Tuzikov SA, Gural ES. Quality of life and clinical characteristics of patients with cancer of various localizations (lungs, stomach, and intestine). Sibirskii vestnik psikhiatrii i narkologii. 2014;(1(82)):55–59. EDN: RZKSGX
- Morrison EJ, Novotny PJ, Sloan JA, et al. Emotional problems, quality of life, and symptom burden in patients with lung cancer. Clin Lung Cancer. 2017;18(5):497–503. doi: 10.1016/j.cllc.2017.02.008
- De Haan JJ, Moshage Y, Renken RJ, et al. Self-reported taste and smell alterations and the liking of oral nutritional supplements with sensory-adapted flavors in cancer patients receiving systemic antitumor treatment. Support Care Cancer. 2021;29(10):5691–5699. doi: 10.1007/s00520-021-06049-4
Supplementary files
